Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H5TU
|
||||
Former ID |
DIB004048
|
||||
Drug Name |
RQ-00000008
|
||||
Synonyms |
CJ-042794; Prostaglandin EP4 antagonists (chronic inflammatory pain), Pfizer; Prostaglandin EP4 antagonists (chronic inflammatory pain), RaQualia
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [541166] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H17ClFNO4
|
||||
InChI |
InChI=1S/C22H17ClFNO4/c1-13(14-2-4-15(5-3-14)22(27)28)25-21(26)19-12-16(23)6-11-20(19)29-18-9-7-17(24)8-10-18/h2-13H,1H3,(H,25,26)(H,27,28)/t13-/m0/s1
|
||||
InChIKey |
MWBNCZHVEXULBD-ZDUSSCGKSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin E2 receptor, EP4 subtype | Target Info | Antagonist | [543780] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.